Skip to main content


Meet with our product experts in one-on-one virtual sessions and get a deep insight into our API Pharma product offerings

Our experts will answer your questions, provide advice, and help you understand our product better.

Set up a meeting

Verified

Dr. Reddy’s Laboratories Ltd. is an integrated pharmaceutical company committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics, and Proprietary Products – Dr. Reddy’s is an active pharma API manufacturing company and pharmaceutical ingredient supplier for foremost formulators and offers a portfolio of products and services, including APIs, custom pharmaceutical services, generics, biosimilars, and differentiated formulations.

Our API pharma business caters to leading innovator and generic companies across the US, Europe, Latin America, Japan, Korea, and other emerging markets. We consistently deliver high-quality APIs with deep technical strengths in developing complex APIs such as steroids, peptides, complex long-chain synthesis, and oncology.

As a pharmaceutical API manufacturer, our major therapeutic areas focus on gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. Dr. Reddy’s operates in global markets and is one of the top API manufacturers in the USA. As a pharma API supplier our major markets include – the USA, Europe, India, Russia, and other CIS countries.

About Dr. Reddy’s API Business

250+ APIs

8 Manufacturing
Sites

More than 1750 drug master files
across global markets

50+ Pipeline molecules
(Filed + under development)

State-of-the-art R&D centers
in India, U.K., U.S. & Netherlands

Over 1300+ research scientists
working on various projects

Our Achievements

Resources

Our Capabilities

API Manufacturing

With an industry-leading portfolio of generic APIs and a proven track record in drug product development, we are among the earliest pharma API manufacturers with a vast portfolio of APIs and the preferred API partner of choice for pharma companies than 80+ countries. Our API manufacturing facilities are complemented by formulation facilities supplying various dosage forms.

We are multi-sourced on our KSMs for a sustainable supply; we have reliable KSM suppliers to ensure timely deliveries and adhere to stringent specifications. Moreover, with additional capacity enhancement and API manufacturing facilities, we are among the top API manufacturing companies in India. As a result, we are well-positioned to meet the global demands of essential APIs and future supply requirements.

As a top API manufacturer in India, our API manufacturing facilities are operated in accordance with cGMP (ICH Q7) and are regularly inspected/audited by international regulatory authorities. We have eight commercial USFDA-inspected manufacturing units, of which six are in India and one in Mexico and the UK.

Research & Development

We have development facilities in Hyderabad, India, and Cambridge, UK, as well as cGMP API manufacturing facilities in India, Mexico, and the UK. Our strong capabilities in synthetic chemistry, analytical chemistry, and process engineering have helped us build a strong portfolio of small molecule APIs across niche areas, including peptides, carbohydrates, prostaglandins, steroids, and highly potent APIs, making us top active pharmaceutical ingredient manufacturers in USA and API suppliers in India. In addition, this expertise has enabled us to develop a strong portfolio and API producers in key therapy areas including oncology, cardiovascular and central nervous system. Our capabilities include complex chemical synthesis, HPAPIs, peptides, carbohydrates, and steroids.

Customer Service

Dr. Reddys provides its customers with a superior service experience with an XCEED platform. XCEED will help manage the whole business process in real time. From ordering samples to submitting and tracking their orders, XCEED provides convenience and transparency by providing a platform to interact with Dr. Reddy's interdisciplinary support team, which helps in the timely delivery of the APIs closely.

Regulatory

Dr. Reddy’s has unmatched global regulatory expertise focused on international markets. Our top-class quality and industry-leading compliance are designed to ensure our products meet stringent requirements globally. As an active pharmaceutical ingredient manufacturer, our regulatory affairs (RA) team is one of the strongest in the industry and top API pharma companies, with a dedicated team of more than 50+ experts in regulatory affairs. Our team of regulatory experts understands the complex issues associated with regulatory agencies and assists in approving each complex API by analyzing the latest regulatory trends and quality requirements through active monitoring and proactive assessment of potential risks and enabling early launch advantages.

Dr. Reddy's API supplies high-quality, affordable APIs to leading generic formulations manufacturers and is the preferred API supplier to pharma companies worldwide. Dr. Reddy's API business thrives on the deep technical strengths proven over the last three decades in developing and manufacturing complex APIs.

The API division is strategically working towards becoming the number one API manufacturing companies in the world by focusing on solid innovation, global footprint, and exceptional customer service.

Selecting a world-class API and active pharmaceutical ingredient manufacturer is one of the most critical decisions a pharmaceutical manufacturer will make. So, choose your API wisely from the largest API manufacturers in India. To know more about the portfolio of our APIs and its services, place a query or contact our team at: api@drreddys.com

Disclaimer

No information in this catalog - including any reference to any product or service - constitutes an offer for sale, or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. Products protected under valid patents in India are not available for commercial use but would be available for Section 107A purposes.

X

Meet us at Suite 1123, 1125, 1126

March 18 - 21, 2024

LOTTE New York Palace Hotel 455 Madison Avenue, New York, NY 10022 (Madison at 50th Street)

Don’t forget to schedule a meeting

Schedule now